Craig-Hallum analyst William Bonello maintained a Buy rating on Repligen (RGEN – Research Report) today. The company’s shares closed yesterday ...

Check the time stamp on this data. Updated AI-Generated Signals for Repligen Corporation (RGEN) available here: RGEN. Type a ...

Life sciences group Repligen (RGEN) is set for healthy revenue growth, boosted by its “underappreciated” AI capabilities.Maximize Your ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have ...

(HRMY) and Repligen (RGEN). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of strategies for discovering ...

(HRMY) and Repligen (RGEN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. The best way to find great value stocks is to ...

Repligen (RGEN) shares ended the last trading session 3.7% higher at $174.24. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

SEGALL BRYANT & HAMILL, LLC has opened a new $19.0M position in $RGEN, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2024 ...